HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters by Arash GhorbanniaDelavar (22563696)

“…</p><p dir="ltr">Compared to the ECIB algorithm and previous approaches, HDECO achieved significant improvements:</p><ul><li><b>Up to 10% reduction in energy consumption</b></li><li><b>8% decrease in overall execution cost</b></li><li><b>Better real execution time and fewer unnecessary migrations</b></li></ul><p dir="ltr">This makes HDECO an effective and lightweight solution for instance-intensive cloud workflows.…”

The SPAM fitted on empirical data. by Kimmo Sorjonen (495847)

The effect of pre-RT D-dimer levels on post-RT changes in D-dimer levels and on survival rates. by Huriye Senay Kiziltan (22298378)

Subjects:

ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21). by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to RT and/or CRT response. by Huriye Senay Kiziltan (22298378)

Subjects:

Univariate and multivariable analyses for progression free survival. by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values. by Huriye Senay Kiziltan (22298378)

Subjects:

Univariate and multivariable analyses for OS. by Huriye Senay Kiziltan (22298378)

Subjects:

Characteristics of LC patients. by Huriye Senay Kiziltan (22298378)

Subjects:

Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. by Huriye Senay Kiziltan (22298378)

Subjects:

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

Subjects:

ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24). by Huriye Senay Kiziltan (22298378)

Subjects:

Flowchart of this study. by Huriye Senay Kiziltan (22298378)

Subjects:

RT characteristics and D-dimer, OS and PFS of patients. by Huriye Senay Kiziltan (22298378)

Subjects:

Patient characteristics before and after propensity score matching. by Anna D. Ware (19688153)

Subjects:

Unadjusted and adjusted odds ratios (95% confidence interval) for associations between patients who were prescribed aspirin at baseline and the occurrence of post-COVID-19 acute th... by Anna D. Ware (19688153)

Subjects:

Forest plot displaying the association (odds ratio [95% CI]) between patients who were prescribed aspirin at baseline and the occurrence of post-COVID-19 acute thromboembolic disor... by Anna D. Ware (19688153)

Subjects:

Patient flowchart. by Anna D. Ware (19688153)

Subjects:

Frequency of post-COVID-19 acute thromboembolic disorders among aspirin users vs. non-users within 12 months following index date. by Anna D. Ware (19688153)

Subjects:

Experimental conditions during the cold stress exposure. by Oumayma Arbani (21001472)

Subjects: